Control Bionics (ASX:CBL)
ASX announcement history & article coverage
Transparent by design.
Announcments by Control Bionics (ASX:CBL) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification of cessation of securities - CBL
Notification regarding unquoted securities - CBL
Notice of General Meeting/Proxy Form
Change in substantial holding - Phoenix
SPP Cleansing Notice
Security Purchase Plan Offer Document
Placement cleansing notice
Control Bionics issues nearly 30 million shares under Section 708A(5)(e) notice
Application for quotation of securities - CBL
Life Science Intelligence Asia Presentation
Control Bionics to present at Life Science Intelligence Asia
Proposed issue of securities - CBL
Proposed issue of securities - CBL
Proposed issue of securities - CBL
Completion of Placement
Control Bionics announces $10 million capital raising via placement and Share Purchase Plan
Trading Halt
Pause in Trading
Control Bionics Limited trading paused pending further announcement
Investor Webinar
Change in substantial holding - Nightingale
Change in substantial holding - Phoenix
Commercial Momentum Presentation
Control Bionics advances commercial partnerships and expands market access across assistive tech, sports, and medical sectors
Commercial Momentum, Execution and Market Access Update
Proposed issue of securities - CBL
Initial Director's Interest Notice - Opie
Final Director's Interest Notice - Phillips
Leading neurotechnology pioneer Prof Nicholas Opie joins CBL
Control Bionics Strategic Transition Presentation
Quarterly Activities/Appendix 4C Cash Flow Report
Control Bionics advances distributor model, secures US partnership, gains German reimbursement, reports $1.2M revenue and $1.7M cash outflow